Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 463 across all filing types
Latest filing 2023-10-10 Regulatory Filings
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Disclosure of material issue
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges (BSE and NSE) regarding a material event update about a legal dispute involving the promoter and alleged claims on properties. It references compliance with SEBI Listing Obligations Regulation 30, which mandates disclosure of material events. The document does not contain financial statements, detailed financial data, or comprehensive report content. It is a notification of a material event rather than a full report or detailed filing. The length is under 5,000 characters and it serves as an announcement to shareholders and exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-10-10 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the quarter ended September 30, 2023. It references insider trading regulations and trading restrictions but does not contain any financial data, results, or detailed report content. The document is short (1633 characters) and serves as an announcement related to compliance and trading restrictions rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2023-09-29 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed consolidated Scrutinizers Report on the 8th Annual General Meeting (AGM) of Lasa Supergenerics Limited held on September 27, 2023. It includes voting results on various resolutions proposed at the AGM, such as adoption of audited financial statements, appointment of directors, and appointment of statutory auditors. The report is prepared by a practicing company secretary as per Section 108 of the Companies Act, 2013, and includes detailed vote counts and percentages for each resolution. The document is not the Annual Report itself, nor is it a proxy solicitation or management discussion. It is a formal report on the voting results of the AGM resolutions, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial (15,000 characters), and it contains detailed voting data, not just an announcement of report publication or a certification. Therefore, the correct classification is DVA with high confidence.
2023-09-28 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is a detailed summary of the proceedings of the 8th Annual General Meeting (AGM) of LASA Supergenerics Limited held on September 27, 2023. It includes the date, time, venue, attendance, agenda items, resolutions passed, and a Q&A session with shareholders. The document references compliance with SEBI regulations and the Companies Act, 2013, and mentions voting procedures and the appointment of a scrutinizer. It does not contain full financial statements or detailed financial performance data but rather a summary of the meeting and discussions. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM. The document is not an announcement of voting results (DVA) since it states that voting results will be submitted later. It is also not an Annual Report (10-K) or Interim Report (IR) as it lacks comprehensive financial data. Therefore, the correct classification is AGM Information (AGM-R).
2023-09-28 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a public notice published as a newspaper advertisement regarding the scheduling of the 8th Annual General Meeting (AGM) of LASA Supergenerics Limited. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations and Ministry of Corporate Affairs circulars. The text includes details about the AGM date, voting procedures, and availability of the Annual Report and Notice of AGM on company and stock exchange websites. There is no actual financial data or detailed report content present; rather, it is an announcement informing shareholders about the AGM and related voting information. The document length is about 15,000 characters, but the content is clearly an announcement of the AGM and related procedural information, not the AGM materials themselves. Therefore, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices related to it. Given the detailed nature and regulatory references, confidence is high.
2023-09-06 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal communication from LASA Supergenerics Limited addressed to stock exchanges, reporting the outcome of a Board Meeting held on September 2, 2023. It details the approval of the Notice of the 8th Annual General Meeting (AGM), scheduling of the AGM, approval of the Director's Report including Corporate Governance and Management Discussion and Analysis for the financial year ended March 31, 2023, appointment of a scrutinizer for the AGM, re-appointment of a director, and closure of the Register of Members. The document also includes detailed information about the re-appointed director. The content is primarily an announcement of board decisions and director re-appointment, not the actual Annual Report or Director's Report itself. It does not contain financial statements or detailed financial analysis but rather informs about governance and meeting arrangements. Therefore, the document fits best under Board/Management Information (MANG) as it announces board meeting outcomes and management changes, specifically the re-appointment of a director and AGM details.
2023-09-02 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.